Cover Image

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022

Saved in:

Bibliographic Details
Main Authors:	Francesco Sessa (Author), Tarek Magdy (Author), Chonlaphat Sukasem (Author), George P. Patrinos (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023)

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
by: Nathalie K. Zgheib, et al.
Published: (2020)

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
by: Wojciech Miltyk, et al.
Published: (2022)

Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow
by: Efstathia Giannopoulou, et al.
Published: (2019)

A Novel Text-Mining Approach for Retrieving Pharmacogenomics Associations From the Literature
by: Maria-Theodora Pandi, et al.
Published: (2020)

Adoption of Pharmacogenomic Testing: A Marketing Perspective
by: Margarita-Ioanna Koufaki, et al.
Published: (2021)

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy
by: Zeina N. Al-Mahayri, et al.
Published: (2020)

Whole Genome Sequencing in Pharmacogenomics
by: George P Patrinos, et al.
Published: (2015)

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
by: Mohitosh Biswas, et al.
Published: (2024)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
by: Therdpong Tempark, et al.
Published: (2022)

Do future healthcare professionals advocate for pharmacogenomics? A study on medical and health sciences undergraduate students
by: Hanan Al-Suhail, et al.
Published: (2024)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
by: Ai-Hoc Nguyen, et al.
Published: (2023)

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
by: Mohitosh Biswas, et al.
Published: (2022)

Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions
by: Stavros Simeonidis, et al.
Published: (2019)

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children
by: Theodora eKatsila, et al.
Published: (2015)

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
by: Yaowaluck Hongkaew, et al.
Published: (2021)

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
by: Teerapat Majam, et al.
Published: (2023)

Pharmacometabolomics informs viromics towards precision medicine
by: Aggeliki Balasopoulou, et al.
Published: (2016)

Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study
by: Vasileios Fragoulakis, et al.
Published: (2023)

Editorial: Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022
by: Sylvia D. Klomp, et al.
Published: (2023)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
by: Napatrupron Koomdee, et al.
Published: (2022)

A Comprehensive Review of <i>HLA</i> and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
by: Chiraphat Kloypan, et al.
Published: (2021)

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
by: Effrosyni Mendrinou, et al.
Published: (2020)

Molecular identification of HLA‐B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription
by: Kanoot Jaruthamsophon, et al.
Published: (2024)

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
by: José A. G. Agúndez, et al.
Published: (2022)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
by: Kanyawan Tiwattanon, et al.
Published: (2022)

Editorial: Editor's feature: negative findings in pharmacogenetics and pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2023)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
by: Augusto Garcia-Agundez, et al.
Published: (2022)

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
by: Chalitpon Na nakorn, et al.
Published: (2020)

Pharmacogenomic study reveals new variants of drug metabolizing enzyme and transporter genes associated with steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in Thai autism spectrum disorder patients
by: Sadeep Medhasi, et al.
Published: (2016)

HLA-B*58:01 for allopurinol-induced cutaneous adverse drug reactions: Implication for clinical interpretation in Thailand
by: Chonlaphat Sukasem, et al.
Published: (2016)

A Pharmacokinetic Analysis and Pharmacogenomic Study of 6-mercaptopurine
by: Vicha A, et al.
Published: (2015)

10 Years of Pharmacogenetics and Pharmacogenomics
Published: (2020)

Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report
by: Tan-kam T, et al.
Published: (2013)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
by: Augusto Garcia-Agundez, et al.
Published: (2023)

Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
by: Francisco Abad-Santos, et al.
Published: (2024)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
by: Mohitosh Biswas, et al.
Published: (2022)

The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand
by: Bushyakanist A, et al.
Published: (2015)

Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections
by: Sumonrat Chuwongwattana, et al.
Published: (2020)

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors
by: Natchaya Vanwong, et al.
Published: (2020)